Connection

LI-YUAN YU-LEE to Transcription Factors

This is a "connection" page, showing publications LI-YUAN YU-LEE has written about Transcription Factors.
Connection Strength

0.396
  1. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. J Biol Chem. 1994 Oct 21; 269(42):26076-82.
    View in: PubMed
    Score: 0.055
  2. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014 Jan 01; 192(1):178-88.
    View in: PubMed
    Score: 0.051
  3. The transcription factor interferon regulatory factor-1 is expressed during both early G1 and the G1/S transition in the prolactin-induced lymphocyte cell cycle. Mol Endocrinol. 1992 Dec; 6(12):2236-43.
    View in: PubMed
    Score: 0.048
  4. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res. 2008 Jul 01; 68(13):5460-8.
    View in: PubMed
    Score: 0.035
  5. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004 May 01; 64(9):3072-8.
    View in: PubMed
    Score: 0.026
  6. Transcriptional regulation of CCSP by interferon-gamma in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2003 Jan; 284(1):L108-18.
    View in: PubMed
    Score: 0.024
  7. Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1. Biol Reprod. 2002 Feb; 66(2):393-400.
    View in: PubMed
    Score: 0.023
  8. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. Oncogene. 2022 Feb; 41(6):757-769.
    View in: PubMed
    Score: 0.022
  9. Stimulation of interferon regulatory factor-1 by prolactin. Lupus. 2001; 10(10):691-9.
    View in: PubMed
    Score: 0.021
  10. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. J Biol Chem. 1997 Oct 24; 272(43):26841-9.
    View in: PubMed
    Score: 0.017
  11. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med. 1997 May; 215(1):35-52.
    View in: PubMed
    Score: 0.016
  12. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. Oncotarget. 2017 Feb 07; 8(6):10145-10160.
    View in: PubMed
    Score: 0.016
  13. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol. 1994 Mar; 8(3):345-55.
    View in: PubMed
    Score: 0.013
  14. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol. 1990 Jun; 10(6):3087-94.
    View in: PubMed
    Score: 0.010
  15. Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells. Endocrinology. 2001 Jan; 142(1):98-107.
    View in: PubMed
    Score: 0.005
  16. Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells. Eur Cytokine Netw. 2000 Sep; 11(3):435-42.
    View in: PubMed
    Score: 0.005
  17. Localization of interferon regulatory factor-1 (IRF-1) in nonpregnant human endometrium: expression of IRF-1 is up-regulated by prolactin during the secretory phase of the menstrual cycle. J Clin Endocrinol Metab. 1999 Nov; 84(11):4260-5.
    View in: PubMed
    Score: 0.005
  18. The proline-rich motif is necessary but not sufficient for prolactin receptor signal transduction. Ann N Y Acad Sci. 1995 Sep 07; 766:282-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.